Therefore, it is most likely that the significantly increased infiltration of CD8+ T cells into the tumors and the enhanced cytotoxic activity of these T cells in the mice immunized with non-replicable MC38 CRC cells plus rGRA6Nt adjuvant play a key protective role in the anti-cancer protective activity induced by the immunization. Here, CD8A is linked to cancer.